PRISM - Trademark Details
Status: 688 - Notice Of Allowance - Issued
Image for trademark with serial number 88276928
Serial Number
88276928
Word Mark
PRISM
Status
688 - Notice Of Allowance - Issued
Status Date
2021-11-09
Filing Date
2019-01-25
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
260514, 260516 - Three triangles. Triangles touching or intersecting.
Published for Opposition Date
2021-09-14
Attorney Name
Steven A. Abreu
Law Office Assigned Location Code
N40
Employee Name
MMEJE, OBIEZE GINIKANW
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of three overlapping triangles appearing to the left of the stylized word "PRISM".
Goods and Services
Oligonucleotide compounds for scientific or research purposes for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; oligonucleotide delivery agents for scientific or research purposes for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; oligonucleotide compounds for scientific or research purposes for use in targeted gene silencing; drug delivery agents for scientific or research purposes consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies
Goods and Services
Oligonucleotide compounds for medical purposes for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; oligonucleotide delivery agents for medical purposes for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; oligonucleotide compounds for medical purposes for use in targeted gene silencing; drug delivery agents for medical purposes consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies
Goods and Services
Custom manufacture of oligonucleotides for use in genetic research, medical research, pharmaceutical therapies, and the treatment of genetic diseases and disorders
Goods and Services
Research and development of oligonucleotide drug delivery platforms for use in the treatment of genetic diseases and disorders; research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; research and development of oligonucleotide compounds for targeted gene silencing
Classification Information
International Class
040 - Treatment of materials. - Treatment of materials.
US Class Codes
100, 103, 106
Class Status Code
6 - Active
Class Status Date
2019-02-19
Primary Code
040
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-02-19
Primary Code
042
Current Trademark Owners
Party Name
Wave Life Sciences Ltd.
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (public company).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Wave Life Sciences Ltd.
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (public company).
Address
Please log in with your Justia account to see this address.
Party Name
Wave Life Sciences Ltd.
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (public company).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Steven A. Abreu
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2019-01-29NEW APPLICATION ENTERED IN TRAM
2019-02-19NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2019-03-21NOTICE OF DESIGN SEARCH CODE E-MAILED
2019-04-08ASSIGNED TO EXAMINER
2019-04-13NON-FINAL ACTION WRITTEN
2019-04-13NON-FINAL ACTION E-MAILED
2019-04-13NOTIFICATION OF NON-FINAL ACTION E-MAILED
2019-10-11TEAS RESPONSE TO OFFICE ACTION RECEIVED
2019-10-11CORRESPONDENCE RECEIVED IN LAW OFFICE
2019-10-12TEAS/EMAIL CORRESPONDENCE ENTERED
2019-11-16SUSPENSION LETTER WRITTEN
2019-11-16LETTER OF SUSPENSION E-MAILED
2019-11-16NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
2020-06-04ASSIGNED TO LIE
2020-06-07SUSPENSION LETTER WRITTEN
2020-06-07LETTER OF SUSPENSION E-MAILED
2020-06-07NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
2021-01-11NON-FINAL ACTION WRITTEN
2021-01-11NON-FINAL ACTION E-MAILED
2021-01-11NOTIFICATION OF NON-FINAL ACTION E-MAILED
2021-01-11NON-FINAL ACTION WRITTEN
2021-01-11NON-FINAL ACTION E-MAILED
2021-01-11NOTIFICATION OF NON-FINAL ACTION E-MAILED
2021-03-08TEAS CHANGE OF OWNER ADDRESS RECEIVED
2021-03-08TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2021-03-08ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2021-03-08TEAS CHANGE OF CORRESPONDENCE RECEIVED
2021-03-08APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2021-07-08TEAS RESPONSE TO OFFICE ACTION RECEIVED
2021-07-08CORRESPONDENCE RECEIVED IN LAW OFFICE
2021-07-08TEAS/EMAIL CORRESPONDENCE ENTERED
2021-08-09APPROVED FOR PUB - PRINCIPAL REGISTER
2021-08-26NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2021-08-26NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2021-08-26NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2021-09-14PUBLISHED FOR OPPOSITION
2021-09-14OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2021-09-14OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2021-09-14OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2021-11-09NOA E-MAILED - SOU REQUIRED FROM APPLICANT